Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
NeuroVersis Therapeutics ApS
APS
Active
Advertising protection
CVR 45718972
Gothersgade 33A, 1123
København K
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2025 · 1 year old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
NeuroVersis Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
HN
Hussein Nasser Awada
Chief Executive Officer
Chief Executive Officer
2025
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
QUARTZ CAPITAL ApS — 100%
100%
Shareholder
Type
Ownership
Votes
Since
QUARTZ CAPITAL ApS
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on NeuroVersis Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
